Post-licensure surveillance of quadrivalent live attenuated influenza vaccine United States, Vaccine Adverse Event Reporting System (VAERS), July 2013-June 2014

Vaccine

Volumn 33, Issue 16, 2015, Pages 1987-1992

  Haber, Penina ^a   Moro, Pedro L ^a   Cano, Maria ^a   Lewis, Paige ^a   Stewart, Brock ^a   Shimabukuro, Tom T ^a  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

Author keywords

Live attenuated influenza vaccine; Post licensure surveillance; Vaccine Adverse Event Reporting System; Vaccine safety

Indexed keywords

AMINOTRANSFERASE; INFLUENZA VACCINE; LIVE VACCINE;

ABDOMINAL PAIN; ABSCESS; ACUTE DISSEMINATED ENCEPHALOMYELITIS; ACUTE OTITIS MEDIA; ADOLESCENT; ADULT; AMINOTRANSFERASE BLOOD LEVEL; ANAPHYLACTOID PURPURA; ANGIONEUROTIC EDEMA; APPARENT LIFE THREATENING EVENT; ARTICLE; ASTHMA; ATAXIA; ATAXIC APHASIA; BACTERIAL INFECTION; BAYESIAN LEARNING; BELL PALSY; BRONCHIOLITIS; BRONCHOSPASM; CARDIOVASCULAR DISEASE; CATAPLEXY; CAUSE OF DEATH; CELLULITIS; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR TUMOR; CHEMOTHERAPY INDUCED EMESIS; CHILD; CONTROLLED STUDY; CONVERSION DISORDER; COUGHING; CROUP; DATA MINING; DEATH; DEHYDRATION; DIARRHEA; DISABILITY; DRUG FATALITY; DRUG FEVER; DRUG HYPERSENSITIVITY; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; DYSPNEA; FAILURE TO THRIVE; FAINTNESS; FEBRILE CONVULSION; FEMALE; FOOT AND MOUTH DISEASE; FRACTURE; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL SYMPTOM; GROUPS BY AGE; HEART INFARCTION; HEMATOMA; HOSPITALIZATION; HUMAN; HYPERTHERMIA; IDIOPATHIC THROMBOCYTOPENIC PURPURA; INFLUENZA A; INFLUENZA VACCINATION; INTUSSUSCEPTION; LABYRINTHITIS; LEG PAIN; LENGTH OF STAY; LICENSING; LOW BACK PAIN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MEDICATION ERROR; MENINGOENCEPHALITIS; MIDDLE AGED; MUCOCUTANEOUS LYMPH NODE SYNDROME; MUSCULOSKELETAL DISEASE; MYOCARDITIS; MYOSITIS; NARCOLEPSY; OPTIC NEURITIS; PARESTHESIA; PERICARDITIS; PNEUMONIA; PREGNANT WOMAN; PRENATAL EXPOSURE; PRESCHOOL CHILD; PRIORITY JOURNAL; PSYCHOSIS; RESPIRATORY DISTRESS; RETROSPECTIVE STUDY; SCHOOL CHILD; SEIZURE; SIDE EFFECT; STEVENS JOHNSON SYNDROME; SUBARACHNOID HEMORRHAGE; SYNOVITIS; TACHYPNEA; UNITED STATES; UPPER RESPIRATORY TRACT INFECTION; URTICARIA; VASCULAR TUMOR; VASCULITIS; VERTIGO; VIRUS ENCEPHALITIS; WALKING DIFFICULTY; WEAKNESS; WHEEZING; YOUNG ADULT; HEALTH SURVEY; HISTORY; IMMUNOLOGY; INFLUENZA, HUMAN; MORTALITY; PREGNANCY;

ADOLESCENT; ADULT; ADVERSE DRUG REACTION REPORTING SYSTEMS; CHILD; CHILD, PRESCHOOL; FEMALE; HISTORY, 21ST CENTURY; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MIDDLE AGED; MORTALITY; POPULATION SURVEILLANCE; PREGNANCY; UNITED STATES; VACCINES, ATTENUATED; YOUNG ADULT;

EID: 84933181768     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2015.01.080     Document Type: Article

References (33)

1. Food and Drug Administration. June 17, 2003 approval letter-Influenza virus vaccine lives intranasal. [accessed February 2014]. http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm123753.htm.
2. MedImmune, INC. FluMist® Package Insert (circular). [accessed September 2013]. http://www.medimmune.com/docs/default-source/pdfs/flumist_pi.pdf.
3. Grohskopf L.A., Shay D.K., Shimabukuro T.T., Leslie Z., Sokolow M.S., Wendy A.K., et al. Centers for Disease Control and Prevention (CDC). Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), United States. MMWR 2013, 62(RR07):1-43.
4. Centers for Disease Control and Prevention (CDC) Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP) - United States, 2014-15 influenza season. MMWR Morb Mortal Wkly Rep 2014, August, 63(32):691-697.
5. Food and Drug Administration. FluMist® Quadrivalent (Influenza Vaccine Live, Intranasal). [accessed 02.07.12]. http://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM294307.pdf.
6. Block S.L., Yi T., Sheldon E., Dubovsky F., Falloon J. A randomized double-blinded noninferiority study of quadrivalent live attenuated influenza vaccine in adults. Vaccine 2011, 29:9391-9397.
7. Toback S.L., Levin M.J., Block S.L., Belshe R.B., Ambrose C.S., Falloon J., et al. Quadravalent Ann Arbor Strain live-attenuated influenza vaccine. Expert Rev Vaccin 2012, 11(11):1293-1303.
8. Block S.L., Falloon J., Hirschfield J.A., Krilov L.R., Dubovsky F., Yi T., et al. Immunogenicity and safety of a quadrivalent live attenuated influenza vaccine in children. Pediatr Infect Dis J 2012, 31(7):745-751.
9. Varricchio F., Iskander J., DeStefano F., Ball R., Pless R., Braun M.M., et al. Understanding vaccine safety information from the Vaccine Adverse Event Reporting System. Pediatr Infect Dis J 2004, April, 23(4):287-294. [PMID: 15071280].
10. Zhou W., Pool V., Iskander J.K., English-Bullard R., Ball R., Wise R.P., et al. Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS) United States, 1991-2001. MMWR Surveill Summ 2003, January, 52(1):1-24. [PMID: 12825543].
11. Medical Dictionary for Regulatory Activities. [accessed 13.02.13]. http://www.meddramsso.com/.
12. Code of Federal Regulations. 21 CFR §600.80. [revised 01.04.10]. http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=600.80.
13. DuMouchel W., Pregibon D. Empirical Bayes screening for multi-item associations. Proceeding of the conference on knowledge discovery and data 2001, August, 67-76. ACM Press, San Diego, CA.
14. Szarfman A., Machado S.G., O'Neill R.T. Use of screening algorithms and computer systems to efficiently signal higher-than-expected combinations of drugs and events in the US FDA's Spontaneous Reports database. Drug Saf 2002, 25:381-392.
15. Vellozzi C., Broder K.R., Haber P., Guh A., Nguyen M., Cano M., et al. Adverse events following influenza A (H1N1) 2009 monovalent vaccines reported to the Vaccine Adverse Event Reporting System, United State, October 1, 2009-January 31, 2010. Vaccine 2010, 28:7248-7255.
16. Sejvar J.J., Kohl K.S., Gidudu J., Amato A., Bakshi N., Baxter R., et al. Guillain-Barré syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine 2011, 29:599-661.
17. Ruggeberg J.U., Gold M.S., Bayes J.M., Blum M.D., Bonhoeffer J., Friedlander S., et al. Anaphylaxis: case definition and guidelines for data collection, analysis, and presentation of immunization safety data. Vaccine 2007, 25:5675-5684.
18. Izurieta S.H., Haber P., Wise R.P., Iskander J., Pratt D., Mink C., et al. Adverse events reported following live cold-adapted intranasal influenza vaccine. JAMA 2005, 294(21):2720-2725.
19. Haber P., Moro P., Cano M., Vellozzi C., Lewis P., Woo E.J., et al. Post-licensure surveillance of trivalent live attenuated influenza vaccine in children aged 2-18 years. Vaccine Adverse Event Reporting System (VAERS) 2014, http://dx.doi.org/10.109/jpids/piuo34.
20. Haber P., Moro P.L., McNeil M.M., Lewis P., Woo E.J., Hughes H., et al. Post-licensure surveillance of trivalent live attenuated influenza vaccine in adults, United States, Vaccine Adverse Event Reporting System (VAERS), July 2005-June 2013. Vaccine 2014, 32:6499-6504.
21. Schonberger L.B., Bregman D.J., Sullivan-Bolyai J.Z., et al. Guillain-Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976-1977. Am J Epidemiol 1979, 110(2):105-123.
22. IOM (Institute of Medicine) Adverse effects of vaccines: evidence and causality 2011, The National Academies Press, Washington, DC.
23. Sejvar J.J., Baughman A.L., Wise M., Morganet W. Population incidence of Guillain-Barré syndrome: a systematic review and meta-analysis. Neuroepidemiology 2011, 36(2):123-133.
24. Vellozzi C., Iqbal S., Broder K. Guillain-Barre syndrome, influenza, and influenza vaccination: the epidemiologic evidence. Clin Infect Dis 2014, April, 58(8):1149-1155.
25. Vellozzi C., Iqbal S., Stewart B., Tokars J., DeStefano F. Cumulative risk of Guillain-Barré syndrome among vaccinated and unvaccinated populations during the 2009 H1N1 influenza pandemic. Am J Public Health 2014, April, 104(4):696-701.
26. Baxter R., Bakshi N., Fireman B., Lewis E., Ray P., Vellozzi C., et al. Lack of association of Guillain-Barré syndrome with vaccinations. Clin Infect Dis 2013, July, 57(2):197-204.
27. Redding G., Walker R.E., Hessel C., Virant F.S., Ayars G.H., Bensch G., et al. Safety and tolerability of cold-adapted influenza virus vaccine in children and adolescents with asthma. Pediatr Infect Dis. J 2002, 21:44-48.
28. Brendan F. Update on Effectiveness of Live-Attenuated Versus Inactivated Influenza Vaccines in Children and Adolescents Aged 2-18 Years - US Flu VE Network Advisory Committee on Immunization Practice (ACIP) Meeting Presentation October 29, 2014. Available at . http://www.cdc.gov/vaccines/acip/meetings/downloads/slides-2014-10/flu-03-flannery.
29. Ambrose C. Effectiveness study: Preliminary results from 2013-14. MedImmune. Advisory Committee on Immunization Practice (ACIP) meeting presentation October 29, 2014. Available at . http://www.cdc.gov/vaccines/acip/meetings/downloads/slides-2014-10/flu-03-flannery.
30. Cost A. Influenza vaccine effectiveness: air force children, 2013-2014 influenza season, Advisory Committee on Immunization Practice (ACIP) meeting presentation October 29, 2014. Available at . http://www.cdc.gov/vaccines/acip/meetings/downloads/slides-2014-10/flu-03-flannery.
31. IOM (Institute of Medicine) Preventing medication errors: quality chasm series. Committee on identifying and preventing medication errors 2007, National Academies Press.
32. Haber P., Schembri C.P., Lewis P., Hibbs B., Shimabukuro T. Notes from the field: reports of expired live attenuated influenza vaccine being administered - United States, 2007-2014. MMWR Morb Mortal Wkly Rep 2014, September, 63(35):773. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6335a3.htm [accessed on 06.12.14].
33. Moro P.L., Broder K., Zheteyeva Y., Walton K., Rohan P., Sutherland A., et al. Adverse events in pregnant women following administration of trivalent inactivated influenza vaccine and live attenuated influenza vaccine in the Vaccine Adverse Event Reporting System, 1990-2009. Am J Obstet Gynecol 2011, 204(2):146.e1-146.e7.